Home > Boards > US Listed > Biotechs > Clovis Oncology, Inc. (CLVS)

Yes, we’re heading to $15-16 range. More long

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
sanMillion Member Profile
 
Followed By 8
Posts 206
Boards Moderated 0
Alias Born 03/14/13
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/10/2021 6:05:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 5/5/2021 4:23:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/5/2021 12:48:01 PM
Clovis Oncology drops 7% as Rubraca sales missed estimates amid continued COVID-19 headwinds Seeking Alpha - 5/5/2021 8:28:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 8:06:46 AM
Clovis Oncology EPS beats by $0.08, misses on revenue Seeking Alpha - 5/5/2021 8:01:41 AM
Clovis Oncology Announces First Quarter 2021 Operating Results Business Wire - 5/5/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/28/2021 4:22:06 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/28/2021 4:17:38 PM
Clovis Oncology to Present at the Bank of America 2021 Health Care Conference Business Wire - 4/28/2021 4:05:00 PM
Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5 Business Wire - 4/21/2021 4:00:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/16/2021 4:07:12 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/12/2021 11:53:02 AM
Clovis Oncology's Rubraca shows promise for prostate cancer in phase 1 trial Seeking Alpha - 4/11/2021 10:00:00 AM
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021 Business Wire - 4/10/2021 8:30:00 AM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 3/29/2021 4:33:50 PM
Goldman Sachs reiterates sell for Clovis Oncology on day stock soars 48% Seeking Alpha - 3/19/2021 4:15:35 PM
MP, CLVS, SOS and TNXP among premarket gainers Seeking Alpha - 3/19/2021 8:26:27 AM
Clovis Oncology stock surges as Rubraca meets ovarian cancer late-stage study main goal Seeking Alpha - 3/19/2021 8:20:23 AM
Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients wi... Business Wire - 3/19/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2021 4:16:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 6:46:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 6:43:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 6:41:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2021 6:39:50 PM
sanMillion   Saturday, 05/16/20 09:30:07 AM
Re: None
Post # of 668 
Yes, we’re heading to $15-16 range. More long term investors are entering to the scene.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences